Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 206 Records) |
| Query Trace: Disease and NPM1[original query] |
|---|
| Molecular and clinical significance of FLT3, NPM1, DNMT3A and TP53 mutations in acute myeloid leukemia patients. Molecular biology reports 2023 8 . Ayad M Ali, Gaza F Sal |
| Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based non-intensive therapy. Blood 2023 8 . Jad Othman, Ing Soo Tiong, Jenny O'Nions, Mike Dennis, Katya Mokretar, Adam Ivey, Michael James Austin, Annie-Louise Latif, Mariam Amer, Wei Yee Chan, Charles R Crawley, Francesca Crolla, Joe Wilson Cross, Raymond Dang, Johnathon Elliot, Chun Yew Fong, Sofia Galli, Paolo Gallipoli, Francesca Hogan, Pallavi Kalkur, Anjum Bashir Khan, Pramila Krishnamurthy, John Laurie, Sun Loo, Scott Marshall, Priyanka Mehta, Vidhya Murthy, Sateesh Nagumantry, Srinivas Pillai, Nicola Potter, Rob S Sellar, Tom Taylor, Rui Zhao, Nigel H Russell, Andrew H Wei, Richard Dill |
| Measurable Residual IDH1 before Allogeneic Transplant for Acute Myeloid Leukemia. medRxiv : the preprint server for health sciences 2023 8 . Gege Gui, Laura W Dillon, Niveditha Ravindra, Pranay S Hegde, Georgia Andrew, Devdeep Mukherjee, Zoë Wong, Jeffery Auletta, Firas El Chaer, Evan Chen, Yi-Bin Chen, Adam Corner, Steven M Devine, Sunil Iyer, Antonio Martin Jimenez Jimenez, Marcos J G De Lima, Mark R Litzow, Partow Kebriaei, Stephen R Spellman, Scott L Zeger, Kristin M Page, Christopher S Hourig |
| Allogeneic hematopoietic stem cell transplantation and pre-transplant strategies in patients with NPM1-mutated acute myeloid leukemia: a single center experience. Scientific reports 2023 7 13 (1): 10774. Paul Jäger, Christina Rautenberg, Jennifer Kaivers, Annika Kasprzak, Stefanie Geyh, Ben-Niklas Baermann, Rainer Haas, Ulrich Germing, Thomas Schroeder, Guido Kob |
| Gene mutation profiling and clinical significances in patients with renal cell carcinoma. Clinics (Sao Paulo, Brazil) 2023 7 78 100259. Yongquan Wang, Peng He, Xiaozhou Zhou, Cong Wang, Jian Fu, Dawei Zhang, Deyang Liao, Zhansong Zhou, Chunman Wu, Wei Go |
| The effect of haploidentical hematopoietic stem cell transplantation on comutations based on next-generation sequencing in adult acute myeloid leukemia patients with the FLT3-ITD mutation. Hematological oncology 2023 6 . Feifei Tang, Xiaosu Zhao, Guorui Ruan, Qian Jiang, Hao Jiang, Lanping Xu, Yu Wang, Xiaohui Zhang, Kaiyan Liu, Xiaojun Hua |
| Cytogenetically Normal Acute Myeloid Leukaemia at a Single Centre in South Africa. Hematology/oncology and stem cell therapy 2023 6 16 (4): 397-406. Nicholas Jenkins, Lee-Ann Blanshard, Marian Stone, Estelle Verburgh, Jenna Oosthuizen, Karen Shir |
| UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome. Blood cancer journal 2023 5 13 (1): 88. Julia-Annabell Georgi, Sebastian Stasik, Jan-Niklas Eckardt, Sven Zukunft, Marita Hartwig, Christoph Röllig, Jan Moritz Middeke, Uta Oelschlägel, Utz Krug, Tim Sauer, Sebastian Scholl, Andreas Hochhaus, Tim H Brümmendorf, Ralph Naumann, Björn Steffen, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Kerstin Schäfer-Eckart, Christoph Schliemann, Stefan W Krause, Mathias Hänel, Richard Noppeney, Ulrich Kaiser, Claudia D Baldus, Martin Kaufmann, Carsten Müller-Tidow, Uwe Platzbecker, Wolfgang E Berdel, Hubert Serve, Gerhard Ehninger, Martin Bornhäuser, Johannes Schetelig, Frank Kroschinsky, Christian Thiede, |
| LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study. Blood advances 2023 5 . Loic Vasseur, Laurène Fenwarth, Jérôme Lambert, Stéphane de Botton, Martin Figeac, Céline Villenet, Maël Heiblig, Pierre-Yves Dumas, Christian Récher, Celine Berthon, Emilie Lemasle, Delphine Lebon, Juliette Lambert, Christine Terré, Karine Celli-Lebras, Hervé Dombret, Claude Preudhomme, Meyling H Cheok, Raphaël A Itzykson, Nicolas Duploy |
| DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant. JAMA 2023 3 329 (9): 745-755. Dillon Laura W, Gui Gege, Page Kristin M, Ravindra Niveditha, Wong Zoë C, Andrew Georgia, Mukherjee Devdeep, Zeger Scott L, El Chaer Firas, Spellman Stephen, Howard Alan, Chen Karen, Auletta Jeffery, Devine Steven M, Jimenez Jimenez Antonio Martin, De Lima Marcos J G, Litzow Mark R, Kebriaei Partow, Saber Wael, Weisdorf Daniel J, Hourigan Christopher |
| HLA Class I genotype is associated with relapse risk after allogeneic stem cell transplantation for NPM1-mutated AML. Transplantation and cellular therapy 2023 3 . Narayan Rupa, Niroula Abhishek, Wang Tao, Kuxhausen Michelle, He Meilun, Meyer Everett, Chen Yi-Bin, Bhatt Vijaya Raj, Beitinjaneh Amer, Nishihori Taiga, Sharma Akshay, Brown Valerie I, Kamoun Malek, Diaz Miguel A, Abid Muhammad Bilal, Askar Medhat, Kanakry Christopher G, Gragert Loren, Bolon Yung-Tsi, Marsh Steven G E, Gadalla Shahinaz M, Paczesny Sophie, Spellman Stephen, Lee Stephanie |
| An NGS based MRD evaluation from acute myeloid leukemia patients. International journal of laboratory hematology 2023 2 . Chen Bin, Wang Lingling, Wang Zhe, Zhang Hong, Chen Long, Zhang Lei, Li Jing, Yan Xiaoyan, Zhao Miaoqing, Lin Yani, Ru K |
| Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study. Leukemia 2023 2 . Mrózek Krzysztof, Kohlschmidt Jessica, Blachly James S, Nicolet Deedra, Carroll Andrew J, Archer Kellie J, Mims Alice S, Larkin Karilyn T, Orwick Shelley, Oakes Christopher C, Kolitz Jonathan E, Powell Bayard L, Blum William G, Marcucci Guido, Baer Maria R, Uy Geoffrey L, Stock Wendy, Byrd John C, Eisfeld Ann-Kathr |
| Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes. Hematology (Amsterdam, Netherlands) 2023 2 28 (1): 2180704. Papadopoulou Vasiliki, Schoumans Jacqueline, Basset Valentin, Solly Françoise, Pasquier Jérôme, Blum Sabine, Spertini Olivi |
| Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group. JCO precision oncology 2023 1 7 e2200400. Cantu Miguel D, Kanagal-Shamanna Rashmi, Wang Sa A, Kadia Tapan, Bueso-Ramos Carlos E, Patel Sanjay S, Geyer Julia T, Tam Wayne, Madanat Yazan, Li Peng, George Tracy I, Nichols Meredith M, Rogers Heesun J, Liu Yen-Chun, Aggarwal Nidhi, Kurzer Jason H, Maracaja Danielle L V, Hsi Eric D, Zaiem Feras, Babu Daniel, Foucar Kathryn, Laczko Dorottya, Bagg Adam, Orazi Attilio, Arber Daniel A, Hasserjian Robert P, Weinberg Olga |
| Measurable Residual Disease Monitoring in AML With FLT3-ITD Treated With Intensive Chemotherapy Plus Midostaurin. Blood advances 2024 9 . Frank G Rücker, Lars Bullinger, Sibylle Cocciardi, Sabrina Skambraks, Tamara J Luck, Daniela Weber, Julia Krzykalla, Ema Pozek, Isabelle Janina Schneider, Andrea Corbacioglu, Verena I Gaidzik, Annika Meid, Sophia Aicher, Frank Stegelmann, Anika Schrade, Frauke Theis, Walter Fiedler, Helmut R Salih, Gerald G Wulf, Hans J Salwender, Thomas Schroeder, Katharina S Götze, Michael W M Kühn, Michael Lübbert, Richard F Schlenk, Axel Benner, Felicitas R Thol, Michael Heuser, Arnold Ganser, Hartmut Döhner, Konstanze Döhn |
| Only FLT3-ITD co-mutation did not have a deleterious effect on acute myeloid leukemia patients with NPM1 mutation, but concomitant with DNMT3A co-mutation or a?<?3log reduction of MRD2 predicted poor survival. Annals of hematology 2024 9 . Wenbing Duan, Jinsong Jia, Jing Wang, Xiaohong Liu, Wenjing Yu, Xiaolu Zhu, Ting Zhao, Qian Jiang, Guorui Ruan, Xiaosu Zhao, Hongxia Shi, Yingjun Chang, Yu Wang, Lanping Xu, Xiaohui Zhang, Xiaojun Huang, Hao Jia |
| Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT. Bone marrow transplantation 2024 8 . Razan Mohty, Abdul Hamid Bazarbachi, Myriam Labopin, Jordi Esteve, Nicolaus Kröger, Jan J Cornelissen, Didier Blaise, Gerard Socié, Sébastien Maury, Arnold Ganser, Tobias Gedde-Dahl, Peter von dem Borne, Jean Henri Bourhis, Claude Eric Bulabois, Ibrahim Yakoub-Agha, Caroline Pabst, Stéphanie Nguyen, Patrice Chevallier, Anne Huynh, Ali Bazarbachi, Arnon Nagler, Fabio Ciceri, Mohamad Moh |
| Description of lymphocyte and cytokine profiles in individuals with acute myeloid leukemia associated with FLT3-ITD and NPM1 mutation status. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2024 6 . Rogério Reis, Gabriel S Müller, Mariane M Santos, Allan S Santos, Herbert Santos, Lorene S Santos, Bruno A Lopes, Soraya C Trindade, Roberto J Meyer, Songelí M Frei |
| Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study. Blood cancer journal 2024 6 14 (1): 97. Pierre Hirsch, Jérôme Lambert, Maxime Bucci, Caroline Deswarte, Augustin Boudry, Juliette Lambert, Laurene Fenwarth, Jean-Baptiste Micol, Christine Terré, Karine Celli-Lebras, Xavier Thomas, Hervé Dombret, Nicolas Duployez, Claude Preudhomme, Raphael Itzykson, Francois Delhomme |
| Molecular, clinical and therapeutic determinants of outcome in NPM1 mutated AML. Blood 2024 5 . Jad Othman, Nicola Potter, Adam Ivey, Yanis Tazi, Elli Papaemmanuil, Jelena Jovanovic, Sylvie D Freeman, Amanda Frances Gilkes, Rosemary E Gale, Tanya Rapoz-D'Silva, Manohursingh Runglall, Michelle Kleeman, Pawan Dhami, Ian Thomas, Sean Johnson, Joanna Canham, James Durrell Cavenagh, Panagiotis Kottaridis, Claire Arnold, Hans Beier Ommen, Ulrik Malthe Overgaard, Mike Dennis, Alan Kenneth Burnett, Charlotte S Wilhelm-Benartzi, Brian Jp Huntly, Nigel H Russell, Richard James Dill |
| Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia. Bone marrow transplantation 2024 11 . Gege Gui, Niveditha Ravindra, Pranay S Hegde, Georgia Andrew, Devdeep Mukherjee, Zoë Wong, Jeffery J Auletta, Firas El Chaer, Evan C Chen, Yi-Bin Chen, Adam Corner, Steven M Devine, Sunil G Iyer, Antonio Martin Jimenez Jimenez, Marcos J G De Lima, Mark R Litzow, Partow Kebriaei, Wael Saber, Stephen R Spellman, Scott L Zeger, Kristin M Page, Laura W Dillon, Christopher S Hourig |
| Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multi-center Cohort Study. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 11 . Guopan Yu, Yu Zhang, Sijian Yu, Zhao Yin, Guangyang Weng, Na Xu, Xin Du, Dongjun Lin, Jie Xiao, Zhiqiang Sun, Hongyu Zhang, Xinquan Liang, Ziwen Guo, Weihua Zhao, Min Dai, Zhiping Fan, Li Xuan, Hui Liu, Dan Xu, Jieyu Ye, Xuejie Jiang, Pengcheng Shi, Hua Jin, Qifa L |
| Multiomic profiling identifies predictors of survival in African American patients with acute myeloid leukemia. Nature genetics 2024 10 . Andrew Stiff, Maarten Fornerod, Bailee N Kain, Deedra Nicolet, Benjamin J Kelly, Katherine E Miller, Krzysztof Mrózek, Isaiah Boateng, Audrey Bollas, Elizabeth A R Garfinkle, Omolegho Momoh, Foluke A Fasola, Hannah O Olawumi, Nuria Mencia-Trinchant, Jean F Kloppers, Anne-Cecilia van Marle, Eileen Hu, Saranga Wijeratne, Gregory Wheeler, Christopher J Walker, Jill Buss, Adrienne Heyrosa, Helee Desai, Andrea Laganson, Ethan Hamp, Yazan Abu-Shihab, Hasan Abaza, Parker Kronen, Sidharth Sen, Megan E Johnstone, Kate Quinn, Ben Wronowski, Erin Hertlein, Linde A Miles, Alice S Mims, Christopher C Oakes, James S Blachly, Karilyn T Larkin, Bethany Mundy-Bosse, Andrew J Carroll, Bayard L Powell, Jonathan E Kolitz, Richard M Stone, Cassandra Duarte, Diana Abbott, Maria L Amaya, Craig T Jordan, Geoffrey L Uy, Wendy Stock, Kellie J Archer, Electra D Paskett, Monica L Guzman, Ross L Levine, Kamal Menghrajani, Debyani Chakravarty, Michael F Berger, Daniel Bottomly, Shannon K McWeeney, Jeffrey W Tyner, John C Byrd, Nathan Salomonis, H Leighton Grimes, Elaine R Mardis, Ann-Kathrin Eisfe |
| Characteristics and Prognosis of "Acute Promyelocytic Leukemia-like" Nucleophosmin-1-Mutated Acute Myeloid Leukemia in a Retrospective Patient Cohort. Biomedicines 2024 10 12 (10): . Vasiliki Papadopoulou, Giulia Schiavini, Gregoire Stalder, Valentin Basset, Jacqueline Schoumans, Mitja Nabergoj, Muriel Schall |
| Flow cytometric measurable residual disease in adult acute myeloid leukemia: a preliminary report from Eastern India. Journal of hematopathology 2024 1 16 (1): 17-25. Neha Singh, Avinash Gupta, Sujeet Kumar, Gojiri Mawalankar, Bhumika Gupta, Nilesh Dhole, RohitKumar Kori, Anil Sin |
| Mutations Highly Specific for Secondary AML are Associated with Poor Outcomes in ELN Favorable Risk NPM1-mutated AML. Blood advances 2024 1 . Onyee Chan, Najla H Al Ali, Hammad Tashkandi, Austin Ellis, Somedeb Ball, Justin Grenet, Caroline Hana, Yehuda Deutsch, Ling Zhang, Mohammad O Hussaini, Jinming Song, Seongseok Yun, Chetasi Talati, Andrew T Kuykendall, Eric Padron, Alison R Walker, Gail J Roboz, Pinkal Desai, David A Sallman, Kendra L Sweet, Rami S Komrokji, Jeffrey E Lanc |
| Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1-mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party. American journal of hematology 2024 1 . Nour Moukalled, Myriam Labopin, Jurjen Versluis, Gérard Socié, Didier Blaise, Urpu Salmenniemi, Alessandro Rambaldi, Tobias Gedde-Dahl, Eleni Tholouli, Nicolaus Kröger, Jean-Henri Bourhis, Peter Von Dem Borne, Etienne Daguindau, Edouard Forcade, Arnon Nagler, Jordi Esteve, Fabio Ciceri, Ali Bazarbachi, Mohamad Moh |
| Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2024 1 JCO2300943. Nigel H Russell, Charlotte Wilhelm-Benartzi, Jad Othman, Richard Dillon, Steven Knapper, Leona M Batten, Joanna Canham, Emily L Hinson, Sophie Betteridge, Ulrik Malthe Overgaard, Amanda Gilkes, Nicola Potter, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Sylvie D Freeman, Mike Dennis, |
| Impact of myelodysplasia-related and additional gene mutations in intensively treated patients with NPM1-mutated AML. HemaSphere 2025 1 9 (1): e70060. Sibylle Cocciardi, Maral Saadati, Nina Weiß, Daniela Späth, Silke Kapp-Schwoerer, Isabelle Schneider, Annika Meid, Verena I Gaidzik, Sabrina Skambraks, Walter Fiedler, Michael W M Kühn, Ulrich Germing, Karin T Mayer, Michael Lübbert, Elli Papaemmanuil, Felicitas Thol, Michael Heuser, Arnold Ganser, Lars Bullinger, Axel Benner, Hartmut Döhner, Konstanze Döhn |
- Page last reviewed:Feb 1, 2024
- Content source: